Recombinant Protein Drug R&D Market, Global Outlook and Forecast 2022-2028

February 2022 | 108 pages | ID: RA13C700667EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Recombinant Protein Drug R&D in Global, including the following market information:

Global Recombinant Protein Drug R&D Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Recombinant Protein Drug R&D market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Peptide Hormones Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Recombinant Protein Drug R&D include Eli Lilly, Novo Nordisk, Amgen, Merck, Sanofi, Pfizer, Roche, Gensci and Ankebio, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Recombinant Protein Drug R&D companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Recombinant Protein Drug R&D Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Protein Drug R&D Market Segment Percentages, by Type, 2021 (%)

• Peptide Hormones
• Hematopoietic Factor
• Cytokines
• Plasma Protein Factor
• Recombinase
• Fusion Protein
• Other

Global Recombinant Protein Drug R&D Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Recombinant Protein Drug R&D Market Segment Percentages, by Application, 2021 (%)

• Diabetes
• Dwarfism
• Hemophilia
• Heart Disease
• Cancer
• Other

Global Recombinant Protein Drug R&D Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Recombinant Protein Drug R&D Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Recombinant Protein Drug R&D revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Recombinant Protein Drug R&D revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Novo Nordisk
• Amgen
• Merck
• Sanofi
• Pfizer
• Roche
• Gensci
• Ankebio
• United Cell
• Sinobioway Hygene
• Kexing
• Dongbao
• 3sbio
• Gan&Lee
• Hengrui

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Recombinant Protein Drug R&D Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Recombinant Protein Drug R&D Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RECOMBINANT PROTEIN DRUG R&D OVERALL MARKET SIZE

2.1 Global Recombinant Protein Drug R&D Market Size: 2021 VS 2028
2.2 Global Recombinant Protein Drug R&D Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Recombinant Protein Drug R&D Players in Global Market
3.2 Top Global Recombinant Protein Drug R&D Companies Ranked by Revenue
3.3 Global Recombinant Protein Drug R&D Revenue by Companies
3.4 Top 3 and Top 5 Recombinant Protein Drug R&D Companies in Global Market, by Revenue in 2021
3.5 Global Companies Recombinant Protein Drug R&D Product Type
3.6 Tier 1, Tier 2 and Tier 3 Recombinant Protein Drug R&D Players in Global Market
  3.6.1 List of Global Tier 1 Recombinant Protein Drug R&D Companies
  3.6.2 List of Global Tier 2 and Tier 3 Recombinant Protein Drug R&D Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Recombinant Protein Drug R&D Market Size Markets, 2021 & 2028
  4.1.2 Peptide Hormones
  4.1.3 Hematopoietic Factor
  4.1.4 Cytokines
  4.1.5 Plasma Protein Factor
  4.1.6 Recombinase
  4.1.7 Fusion Protein
  4.1.8 Other
4.2 By Type - Global Recombinant Protein Drug R&D Revenue & Forecasts
  4.2.1 By Type - Global Recombinant Protein Drug R&D Revenue, 2017-2022
  4.2.2 By Type - Global Recombinant Protein Drug R&D Revenue, 2023-2028
  4.2.3 By Type - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Recombinant Protein Drug R&D Market Size, 2021 & 2028
  5.1.2 Diabetes
  5.1.3 Dwarfism
  5.1.4 Hemophilia
  5.1.5 Heart Disease
  5.1.6 Cancer
  5.1.7 Other
5.2 By Application - Global Recombinant Protein Drug R&D Revenue & Forecasts
  5.2.1 By Application - Global Recombinant Protein Drug R&D Revenue, 2017-2022
  5.2.2 By Application - Global Recombinant Protein Drug R&D Revenue, 2023-2028
  5.2.3 By Application - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Recombinant Protein Drug R&D Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Protein Drug R&D Revenue & Forecasts
  6.2.1 By Region - Global Recombinant Protein Drug R&D Revenue, 2017-2022
  6.2.2 By Region - Global Recombinant Protein Drug R&D Revenue, 2023-2028
  6.2.3 By Region - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Recombinant Protein Drug R&D Revenue, 2017-2028
  6.3.2 US Recombinant Protein Drug R&D Market Size, 2017-2028
  6.3.3 Canada Recombinant Protein Drug R&D Market Size, 2017-2028
  6.3.4 Mexico Recombinant Protein Drug R&D Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Recombinant Protein Drug R&D Revenue, 2017-2028
  6.4.2 Germany Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.3 France Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.4 U.K. Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.5 Italy Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.6 Russia Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.7 Nordic Countries Recombinant Protein Drug R&D Market Size, 2017-2028
  6.4.8 Benelux Recombinant Protein Drug R&D Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Recombinant Protein Drug R&D Revenue, 2017-2028
  6.5.2 China Recombinant Protein Drug R&D Market Size, 2017-2028
  6.5.3 Japan Recombinant Protein Drug R&D Market Size, 2017-2028
  6.5.4 South Korea Recombinant Protein Drug R&D Market Size, 2017-2028
  6.5.5 Southeast Asia Recombinant Protein Drug R&D Market Size, 2017-2028
  6.5.6 India Recombinant Protein Drug R&D Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Recombinant Protein Drug R&D Revenue, 2017-2028
  6.6.2 Brazil Recombinant Protein Drug R&D Market Size, 2017-2028
  6.6.3 Argentina Recombinant Protein Drug R&D Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue, 2017-2028
  6.7.2 Turkey Recombinant Protein Drug R&D Market Size, 2017-2028
  6.7.3 Israel Recombinant Protein Drug R&D Market Size, 2017-2028
  6.7.4 Saudi Arabia Recombinant Protein Drug R&D Market Size, 2017-2028
  6.7.5 UAE Recombinant Protein Drug R&D Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Recombinant Protein Drug R&D Major Product Offerings
  7.1.4 Eli Lilly Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Novo Nordisk
  7.2.1 Novo Nordisk Corporate Summary
  7.2.2 Novo Nordisk Business Overview
  7.2.3 Novo Nordisk Recombinant Protein Drug R&D Major Product Offerings
  7.2.4 Novo Nordisk Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.2.5 Novo Nordisk Key News
7.3 Amgen
  7.3.1 Amgen Corporate Summary
  7.3.2 Amgen Business Overview
  7.3.3 Amgen Recombinant Protein Drug R&D Major Product Offerings
  7.3.4 Amgen Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.3.5 Amgen Key News
7.4 Merck
  7.4.1 Merck Corporate Summary
  7.4.2 Merck Business Overview
  7.4.3 Merck Recombinant Protein Drug R&D Major Product Offerings
  7.4.4 Merck Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.4.5 Merck Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Recombinant Protein Drug R&D Major Product Offerings
  7.5.4 Sanofi Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Recombinant Protein Drug R&D Major Product Offerings
  7.6.4 Pfizer Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Roche
  7.7.1 Roche Corporate Summary
  7.7.2 Roche Business Overview
  7.7.3 Roche Recombinant Protein Drug R&D Major Product Offerings
  7.7.4 Roche Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.7.5 Roche Key News
7.8 Gensci
  7.8.1 Gensci Corporate Summary
  7.8.2 Gensci Business Overview
  7.8.3 Gensci Recombinant Protein Drug R&D Major Product Offerings
  7.8.4 Gensci Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.8.5 Gensci Key News
7.9 Ankebio
  7.9.1 Ankebio Corporate Summary
  7.9.2 Ankebio Business Overview
  7.9.3 Ankebio Recombinant Protein Drug R&D Major Product Offerings
  7.9.4 Ankebio Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.9.5 Ankebio Key News
7.10 United Cell
  7.10.1 United Cell Corporate Summary
  7.10.2 United Cell Business Overview
  7.10.3 United Cell Recombinant Protein Drug R&D Major Product Offerings
  7.10.4 United Cell Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.10.5 United Cell Key News
7.11 Sinobioway Hygene
  7.11.1 Sinobioway Hygene Corporate Summary
  7.11.2 Sinobioway Hygene Business Overview
  7.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Major Product Offerings
  7.11.4 Sinobioway Hygene Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.11.5 Sinobioway Hygene Key News
7.12 Kexing
  7.12.1 Kexing Corporate Summary
  7.12.2 Kexing Business Overview
  7.12.3 Kexing Recombinant Protein Drug R&D Major Product Offerings
  7.12.4 Kexing Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.12.5 Kexing Key News
7.13 Dongbao
  7.13.1 Dongbao Corporate Summary
  7.13.2 Dongbao Business Overview
  7.13.3 Dongbao Recombinant Protein Drug R&D Major Product Offerings
  7.13.4 Dongbao Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.13.5 Dongbao Key News
7.14 3sbio
  7.14.1 3sbio Corporate Summary
  7.14.2 3sbio Business Overview
  7.14.3 3sbio Recombinant Protein Drug R&D Major Product Offerings
  7.14.4 3sbio Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.14.5 3sbio Key News
7.15 Gan&Lee
  7.15.1 Gan&Lee Corporate Summary
  7.15.2 Gan&Lee Business Overview
  7.15.3 Gan&Lee Recombinant Protein Drug R&D Major Product Offerings
  7.15.4 Gan&Lee Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.15.5 Gan&Lee Key News
7.16 Hengrui
  7.16.1 Hengrui Corporate Summary
  7.16.2 Hengrui Business Overview
  7.16.3 Hengrui Recombinant Protein Drug R&D Major Product Offerings
  7.16.4 Hengrui Recombinant Protein Drug R&D Revenue in Global Market (2017-2022)
  7.16.5 Hengrui Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Recombinant Protein Drug R&D Market Opportunities & Trends in Global Market
Table 2. Recombinant Protein Drug R&D Market Drivers in Global Market
Table 3. Recombinant Protein Drug R&D Market Restraints in Global Market
Table 4. Key Players of Recombinant Protein Drug R&D in Global Market
Table 5. Top Recombinant Protein Drug R&D Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Recombinant Protein Drug R&D Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Recombinant Protein Drug R&D Revenue Share by Companies, 2017-2022
Table 8. Global Companies Recombinant Protein Drug R&D Product Type
Table 9. List of Global Tier 1 Recombinant Protein Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Protein Drug R&D Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Recombinant Protein Drug R&D Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Recombinant Protein Drug R&D Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Recombinant Protein Drug R&D Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Recombinant Protein Drug R&D Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue, (US$, Mn), 2023-2028
Table 30. Eli Lilly Corporate Summary
Table 31. Eli Lilly Recombinant Protein Drug R&D Product Offerings
Table 32. Eli Lilly Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 33. Novo Nordisk Corporate Summary
Table 34. Novo Nordisk Recombinant Protein Drug R&D Product Offerings
Table 35. Novo Nordisk Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 36. Amgen Corporate Summary
Table 37. Amgen Recombinant Protein Drug R&D Product Offerings
Table 38. Amgen Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Recombinant Protein Drug R&D Product Offerings
Table 41. Merck Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Recombinant Protein Drug R&D Product Offerings
Table 44. Sanofi Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Recombinant Protein Drug R&D Product Offerings
Table 47. Pfizer Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Recombinant Protein Drug R&D Product Offerings
Table 50. Roche Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 51. Gensci Corporate Summary
Table 52. Gensci Recombinant Protein Drug R&D Product Offerings
Table 53. Gensci Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 54. Ankebio Corporate Summary
Table 55. Ankebio Recombinant Protein Drug R&D Product Offerings
Table 56. Ankebio Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 57. United Cell Corporate Summary
Table 58. United Cell Recombinant Protein Drug R&D Product Offerings
Table 59. United Cell Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 60. Sinobioway Hygene Corporate Summary
Table 61. Sinobioway Hygene Recombinant Protein Drug R&D Product Offerings
Table 62. Sinobioway Hygene Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 63. Kexing Corporate Summary
Table 64. Kexing Recombinant Protein Drug R&D Product Offerings
Table 65. Kexing Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 66. Dongbao Corporate Summary
Table 67. Dongbao Recombinant Protein Drug R&D Product Offerings
Table 68. Dongbao Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 69. 3sbio Corporate Summary
Table 70. 3sbio Recombinant Protein Drug R&D Product Offerings
Table 71. 3sbio Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 72. Gan&Lee Corporate Summary
Table 73. Gan&Lee Recombinant Protein Drug R&D Product Offerings
Table 74. Gan&Lee Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)
Table 75. Hengrui Corporate Summary
Table 76. Hengrui Recombinant Protein Drug R&D Product Offerings
Table 77. Hengrui Recombinant Protein Drug R&D Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Recombinant Protein Drug R&D Segment by Type in 2021
Figure 2. Recombinant Protein Drug R&D Segment by Application in 2021
Figure 3. Global Recombinant Protein Drug R&D Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Protein Drug R&D Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Protein Drug R&D Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Recombinant Protein Drug R&D Revenue in 2021
Figure 8. By Type - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 9. By Application - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 10. By Region - Global Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 11. By Country - North America Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 12. US Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 16. Germany Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 17. France Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 24. China Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 28. India Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 30. Brazil Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Recombinant Protein Drug R&D Revenue Market Share, 2017-2028
Figure 33. Turkey Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Recombinant Protein Drug R&D Revenue, (US$, Mn), 2017-2028
Figure 37. Eli Lilly Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Novo Nordisk Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Amgen Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Gensci Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ankebio Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. United Cell Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Sinobioway Hygene Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Kexing Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Dongbao Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. 3sbio Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Gan&Lee Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Hengrui Recombinant Protein Drug R&D Revenue Year Over Year Growth (US$, Mn) & (2017-2022)